15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 15 firms covering Exelon Corporation, 4 rate it Buy or better, 10 sit at Hold, and 1 rate it Sell or worse, a hold consensus. Targets span $41.00 to $58.00, a moderate spread. The average target of $50.80 sits 7% above the current $47.30. The rating mix has stayed broadly stable, with Buy-side ratings easing from 5 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.81 next quarter toward $3.04 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS15 ratings
Hold
Strong Buy00%
Buy427%
Hold1067%
Sell17%
Strong Sell00%
Based on 15 analysts giving stock ratings to Exelon Corporation.
As of Jul, 4 of 15 firms rate EXC a Buy (10 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
EXC EPS & revenue forecast
EPS · NEXT QUARTER
$0.81
Range $0.60 – $0.91 · 5 analysts · -6% YoY
Next period, 5 analysts expect Exelon Corporation to earn $0.81 a share (range $0.60 – $0.91), versus $0.86 a year earlier. Full-year consensus is $2.86, growing to $3.04 the year after.
REVENUE · NEXT QUARTER
$7.0B
Range $6.7B – $7.7B · 5 analysts · +4% YoY
Revenue is expected to reach $7.0B (range $6.7B – $7.7B), +4.4% year-over-year. Full-year consensus is $25.4B, rising to $26.2B next year.
Top analysts covering Exelon Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EXC.
#1
JT
Jeremy Tonet
JP Morgan · Rank #89
Hold
$49.00+3.6% to target
Overall win rate
45%
+ Follow
#2
RS
Richard Sunderland
Truist Securities
Hold
$50.00+5.7% to target
Coverage
—
+ Follow
#3
James Thalacker
BMO Capital
Hold
$48.00+1.5% to target
Coverage
—
+ Follow
#4
Shahriar Pourreza
Wells Fargo
Buy
$50.00+5.7% to target
Coverage
—
+ Follow
#5
Sophie Karp
KeyBanc
Sell
$41.00-13.3% to target
Coverage
—
+ Follow
EXC stock forecast FAQ
What is EXC's average 12-month price target?+
The 15 analysts with a live target average $50.80 for Exelon Corporation over the next 12 months, ranging from a $58.00 high to a $41.00 low.
Is EXC stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 15 analyst ratings, 4 are Buy or Strong Buy, 10 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for EXC?+
The Street-high target is $58.00 (Citigroup), and the Street-low is $41.00 (Keybanc). The average of all 15 active targets is $50.80.
How many Wall Street analysts cover EXC?+
15 analysts have an active rating on Exelon Corporation, and 15 firms carry a live 12-month price target.
Who is the most accurate analyst covering EXC?+
Among analysts who currently cover EXC, Jeremy Tonet of JP Morgan has the strongest overall Quantellect track record (Rank #89). Their current call is Hold with a $49.00 target.
What is Exelon Corporation's projected EPS for next quarter?+
The consensus estimate is $0.81 per share (range $0.60 – $0.91) across 5 analysts. Full-year EPS is projected at $2.86, rising to $3.04 the following year.
How much revenue is Exelon Corporation expected to report next quarter?+
Consensus revenue is $7.0B (range $6.7B – $7.7B). Full-year revenue is projected at $25.4B, growing to $26.2B next year.
Have analysts been upgrading or downgrading EXC lately?+
As of Jul, 4 of 15 firms rate EXC a Buy (10 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EXC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
